Quick Answer
Indivior Pharmaceuticals, Inc. reported Total Assets of $1.20 billion for the year ending 2025.
- Indivior Pharmaceuticals, Inc. showed a decrease of -8.7% in Total Assets from 2024 to 2025.
- This data is from Indivior Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $1.38 billion | Q2 2025: $1.45 billion | Q3 2025: $1.42 billion.
- Over the full 5 years of available data (2021 to 2025), Indivior Pharmaceuticals, Inc.'s Total Assets has declined by 34.4%.
- Historical annual values: Fiscal year 2025: $1.20 billion | Fiscal year 2024: $1.32 billion | Fiscal year 2023: $1.76 billion | Fiscal year 2022: $1.77 billion | Fiscal year 2021: $1.83 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: